Delivery Order SPE2DB20D3103-SPE2DB22FN3E6

Award Date 4/11/22
Potential Completion Date 4/12/22
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of Veltassa 8.4 GM powder packets. The $1,547.26 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 22, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,248.46 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM powder packets, a medication used for the treatment of hyperkalemia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,082.84 delivery order covers the supply of Veltassa 8.4 GM Powder Packets to support military and government healthcare programs. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,989.58 delivery order contract is for the pharmaceutical product Veltassa 8.4 GM Powder Packet 30S, with a performance period through November 2024. The contract has a firm-fixed price pricing type and does not utilize any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,840.04 firm fixed-price delivery order contract is for the supply of 4,565,283,546 packets of the medication Veltassa 8.4 GM Powder. The contract has a completion date of July 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Veltassa 8.4 GM Powder Packets. The contract, valued at $3,323.08, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 24, 2025. This contract is not associated with a larger contracting vehicle and does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,456.26 Firm Fixed Price Delivery Order, awarded on December 9, 2024, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,775.46, is for the delivery of 4,564,016,588 packets of Veltassa 8.4 GM Powder, a specialty medication. The contract has a period of performance through March 20, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN3E6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veltassa 16.8 GM Powder Packets. The contract has a ceiling value of $2,827.08 and a performance period through April 12, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. The parent company of Amerisourcebergen Drug Corp is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 12:42 PM